Michael Nath Puri net worth and biography

Michael Puri Biography and Net Worth

Insider of NovoCure

Michael Puri has served as Novocure’s Chief Human Resources Officer since September 2023. He is responsible for the oversight of the company’s global human resources operations, including talent acquisition and organizational development, executive compensation and global strategic development.

Mr. Puri previously served as Vice President, HR Integration lead at CSL Limited, following the company’s acquisition of Vifor Pharma, where he served as Chief Human Resources Officer from 2015 to 2022. He also served as Chief Human Resources Officer at GrandVision, an international leader in optical retailing, from 2013 to 2015. Mr. Puri has also held leadership positions at Staples, Inc. and UCB S.A., a global biopharma company. He earned his bachelor’s degree in economics from the University of Nantes and his master’s degree in strategic marketing from the Grenoble Business School.

What is Michael Nath Puri's net worth?: The estimated net worth of Michael Nath Puri is at least $2.09 million as of October 31st, 2024. Puri owns 110,093 shares of NovoCure stock worth more than $2,088,464 as of March 28th. This net worth evaluation does not reflect any other assets that Puri may own. Learn More about Michael Nath Puri's net worth.
How old is Michael Nath Puri?: Puri is currently 55 years old. There are 7 older executives and no younger executives at NovoCure. The oldest executive at NovoCure is Prof. Yoram Palti M.D., Ph.D., Founder & CTO, who is 86 years old. Learn More on Michael Nath Puri's age.
How do I contact Michael Nath Puri?: The corporate mailing address for Puri and other NovoCure executives is NO. 4 THE FORUM GRENVILLE STREET, ST. HELIER Y9, JE2 4UF. NovoCure can also be reached via phone at 441534756700 and via email at investorinfo@novocure.com. Learn More on Michael Nath Puri's contact information.
Has Michael Nath Puri been buying or selling shares of NovoCure?: Michael Nath Puri has not been actively trading shares of NovoCure over the course of the past ninety days. Most recently, Michal Nath Puri sold 810 shares of the business's stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $15.79, for a transaction totalling $12,789.90. Following the completion of the sale, the insider now directly owns 110,093 shares of the company's stock, valued at $1,738,368.47. Learn More on Michael Nath Puri's trading history.
Who are NovoCure's active insiders?: NovoCure's insider roster includes Michael Ambrogi (COO), Ely Benaim (Insider), Ashley Cordova (CFO), Asaf Danziger (CEO), William Doyle (Executive Chairman), Wilhelmus Groenhuysen (COO), Jeryl Hilleman (Director), Frank Leonard (Insider), Gabriel Leung (Director), Todd Longsworth (General Counsel), Martin Madden (Director), Mukund Paravasthu (COO), Michael Puri (Insider), Pritesh Shah (Insider), William Vernon (Director), and Uri Weinberg (Insider). Learn More on NovoCure's active insiders.
Are insiders buying or selling shares of NovoCure?: During the last twelve months, insiders at the medical equipment provider sold shares 5 times. They sold a total of 3,220 shares worth more than $61,749.10. The most recent insider tranaction occured on November, 1st when EVP Frank X Leonard sold 598 shares worth more than $9,532.12. Insiders at NovoCure own 6.3% of the company. Learn More about insider trades at NovoCure.
Information on this page was last updated on 11/1/2024.

Michael Nath Puri Insider Trading History at NovoCure

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/31/2024	Sell	810	$15.79	$12,789.90	110,093

Michael Nath Puri Buying and Selling Activity at NovoCure

NovoCure Company Overview

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Today's Range

Now: $18.97

$18.31

$19.06

50 Day Range

MA: $21.87

$18.19

$27.02

2 Week Range

Now: $18.97

$11.70

$34.13

Volume

490,446 shs

Average Volume

1,191,815 shs

Market Capitalization

$2.09 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

Michael Puri Biography and Net Worth

What is Michael Nath Puri's net worth?

How old is Michael Nath Puri?

How do I contact Michael Nath Puri?

Has Michael Nath Puri been buying or selling shares of NovoCure?

Who are NovoCure's active insiders?

Are insiders buying or selling shares of NovoCure?